-
Netgear obeys UPC and German anti-antisuit injunctions, yet attempts to thwart Huawei’s patent enforcement through interim license
Read more: Netgear obeys UPC and German anti-antisuit injunctions, yet attempts to thwart Huawei’s patent enforcement through interim licenseNetgear has withdrawn its request for a U.S. antisuit injunction against Huawei’s UPC and German cases, but keeps pursuing an interim license.
-
UPC’s Court of Appeal throws out Alexion’s appeals against Amgen and Samsung Bioepis over validity doubts, reveals €100M value of each dispute
Read more: UPC’s Court of Appeal throws out Alexion’s appeals against Amgen and Samsung Bioepis over validity doubts, reveals €100M value of each disputeThe UPC’s Court of Appeal rejects Alexion’s appeals of decisions to deny preliminary injunctions against Amgen and Samsung Bioepis, where the value of the dispute was set at €100M for each case.
-
Japan’s Nippon Shinyaku vows to fight on in U.S. drug dispute against Sarepta Therapeutics, despite heavy $115 million blow
Read more: Japan’s Nippon Shinyaku vows to fight on in U.S. drug dispute against Sarepta Therapeutics, despite heavy $115 million blowThe Japanese pharma company initiated the drug patent litigation in 2021, but the case eventually boomeranged and a District of Delaware verdict last week ultimately handed Sarepta the win.
-
UPC responds to first antisuit attack on its jurisdiction with first anti-antisuit injunction against Netgear; Huawei also gets one from Munich I Regional Court
Read more: UPC responds to first antisuit attack on its jurisdiction with first anti-antisuit injunction against Netgear; Huawei also gets one from Munich I Regional CourtContext: Last week, the Unified Patent Court’s (UPC) Munich Local Division (LD) entered a final judgment, along with a permanent injunction, for Huawei and against Netgear (December 18, 2024 ip fray article). We subsequently explained the UPC’s FRAND (fair, reasonable and non-discriminatory licensing) reasoning (December 18, 2024 ip fray article) and reported on a trial that the Landgericht München…
-
Dutch government prepares major patent reform, switching from registration to examination system and strengthening climate tech
Read more: Dutch government prepares major patent reform, switching from registration to examination system and strengthening climate techThe Dutch government has started a public consultation for a major overhaul of its national patent law.
-
The venue diversity leaders among Unified Patent Court litigation firms: several firms already have (or have had) cases in nine different venues
Read more: The venue diversity leaders among Unified Patent Court litigation firms: several firms already have (or have had) cases in nine different venuesWe recently asked for input from Unified Patent (UPC) litigation firms whose attorneys have appeared in a wide variety of UPC venues (November 25, 2024 ip fray article). From our conversations with the firms that responded and a couple who elected not to, we got a better understanding of different strategies. As we always knew,…
-
UPC Roundup (1 week): first Nordic-Baltic RD trial, €46K contempt fine, major FRAND injunction, PI over patent approaching expiration, and more
Read more: UPC Roundup (1 week): first Nordic-Baltic RD trial, €46K contempt fine, major FRAND injunction, PI over patent approaching expiration, and moreThis is a summary of developments in and around the Unified Patent Court (UPC) that have happened or become known since the previous UPC Roundup (December 15, 2024 ip fray article). Most roundups sum up what was previously reported (at least on our LinkedIn page), but this present one contains a few items on top….
-
In U.S. court filing that sheds light on UPC and German cases, Huawei claims to have been “repeatedly ghosted by Netgear”
Read more: In U.S. court filing that sheds light on UPC and German cases, Huawei claims to have been “repeatedly ghosted by Netgear”A filing made by Huawei with a U.S. court on Friday accuses Netgear of repeatedly “ghosting” the Chinese innovator when it came to discussing licensing terms.


